The lower percentages of APOBEC3 signature mutations in YTCW motifs in most breast tumors therefore suggests that A3A alone may not account for the observed composite APOBEC3 mutation signature and, moreover, that many tumors in A3A-like group may include contributions from another A3 enzyme, most likely A3B. This evidence concerns the gene APOBEC3B and breast neoplasm.